Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Kidney Int. 2014 Jun 11;87(2):427–433. doi: 10.1038/ki.2014.212

Table 5.

Relationship between baseline biomarker levels* and renal failure in African Americans with type 1 diabetes: univariate analyses

Incidence of renal failure
OR(95% CI)
CYTOKINES

TNF-α (pg/mL)

<3.4 1
3.4–5.3 1.31 (0.57, 3.03)

5.4–8.7 3.47 (1.62, 7.46)b

≥8.8 3.54 (1.39, 9.01)b

p for overall model 0.002

CHEMOKINES

Eotaxin (pg/mL)
<25.5 1
25.5–43.3 2.68 (1.05, 6.81)a

43.4–67.5 4.47 (1.78, 11.23)c

≥67.5 7.29 (2.88, 18.43)c

p for overall model <0.001

IL-8 (pg/mL)
<1.5 1
1.5–3.2 2.90 (1.22, 6.89)a

3.3–6.8 3.26 (1.33, 8.0)b

≥6.9 4.04 (1.63, 10.0)b

p for overall model 0.02

MCP-1 (pg/mL)
<141.5 1
141.5–194.4 1.41 (0.58, 3.40)

194.5–281.3 2.28 (0.98, 5.34)

≥281.4 3.02 (1.27, 7.21)a

p for overall model 0.05

SOLUBLE ADHESION MOLECULES

sICAM-1 (pg/mL)
<122.9 1
122.9–164.2 0.52 (0.21, 1.28)

164.3–232.0 1.78 (0.86, 3.68)

≥232.1 2.20 (1.02, 4.75)a

p for overall model 0.006

sVCAM-1 (pg/mL)
<724.4 1
724.4–932.1 1.0 (0.42, 2.24)

932.2–1185.9 2.28 (1.09, 4.77)a

≥1186.0 2.02 (0.87, 4.73)

p for overall model 0.05
*

Please see abbreviations for each biomarker (in pg/mL, expressed as quartiles) in table 2;

estimated glomerular filtration rate <60 ml/min, dialysis, kidney transplant, or renal failure as the cause of death;

odds ratio (95% confidence interval), with reference to the first quartile of each biomarker.

a

p< 0.05;

b

p< 0.01;

c

p< 0.001.